LAS VEGAS & CINCINNATI--(BUSINESS WIRE)--Aug. 17, 2006-- “No Option Heart Patients” Participated in Cardio Vascu-Grow Phase I Clinical Trial for Innovative Protein Therapy to Stimulate Growth of New Blood Vessels. CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT), in conjunction with the University of Cincinnati, today announced it will be hosting a reunion celebration honoring the patients who participated in a clinical trial during which they received Cardio Vascu-Grow(TM), an innovative protein therapy being evaluated for its potential to stimulate the growth of new blood vessels around blocked arteries in the heart. The event will take place on September 7, 2006 at the Marriott Kingsgate Conference Center Hotel at the University of Cincinnati. A press conference will be held at 11:00 a.m. followed by a luncheon celebration at 12:00 noon.
